T1	Participants 44 110	presyncopal symptom limited lower body negative pressure exposures
T2	Participants 166 242	presyncopal symptom-limited lower body negative pressure (PSL-LBNP) exposure
T3	Participants 424 435	11 subjects
T4	Participants 872 885	nine subjects
T5	Participants 852 870	PSL-LBNP protocols
T6	Participants 356 375	PSL-LBNP tolerance,
